L’Oréal Turkey Continues Supporting Young Women in Science

Beauty-tech company L’Oréal Turkey is supporting the research of four female scientists in the 24th year of its “For Women in Science” Program, conducted in partnership with the Turkish National Commission for UNESCO. Bringing the total number of supported women scientists in Turkey to 132 to date, the program recognizes Assoc. Prof. Dr. Belgin Sever from Anadolu University’s Faculty of Pharmacy, Department of Pharmaceutical Chemistry, for her research developing new drug candidates targeting the mutant SOD1 protein that damages nerve cells in certain forms of ALS.

Dedicated to empowering female researchers and increasing the visibility of their scientific work, the “For Women in Science” Program marks its 24th year in Turkey by backing innovative projects. Among this year’s fellows, Assoc. Prof. Dr. Belgin Sever focuses on discovering novel therapeutic options for Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease.

Computer-Designed Molecules to Be Synthesized and Tested in the Laboratory

In certain forms of ALS—a condition causing the progressive degeneration of motor neurons responsible for muscle control—the intracellular accumulation of mutant SOD1 protein triggers cellular damage. Addressing the limited treatment options currently available, Dr. Sever’s project follows a two-stage methodology:

  • Computer-Aided Molecular Design: Drawing on the chemical structures of existing therapeutic compounds, numerous novel molecules with the potential to target the mutant SOD1 protein will be designed in silico and evaluated for therapeutic suitability.

  • Laboratory Synthesis and Cell Model Testing: Promising candidate molecules identified through computational screening will be synthesized in the laboratory and subsequently tested on ALS cell models to examine their biological efficacy.

The study aims to expand scientific understanding of targeting mutant SOD1-driven neurotoxicity and contribute to the development of future therapeutic strategies for ALS.

Related News